Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169395373> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3169395373 endingPage "27" @default.
- W3169395373 startingPage "24" @default.
- W3169395373 abstract "Purpose. To substantiate the advantages of photoablation with riboflavin as an alternative to the use of Mitomycin-C in excimer laser surgery of the cornea. Material and methods. The work is based on clinical observations of the results of 598 photorefractive and phototherapeutic operations. In all cases, keratoablation was performed after drip, aerosol, or combined saturation of the stroma with 0.1% or 0.25% isotonic riboflavin solution. Corneal OCT was performed on RTVue 100 and RTVue XR100 devices. Keratotopographic and densitometric studies were performed on a TMS-5 device. Results. With photokeratoablation of the stroma saturated with riboflavin, the response aseptic inflammatory and regenerative reactions, the severity and duration of the corneal syndrome decreased. In densitometry and OCT studies, an increase in optical density was noted with the formation of a membrane structure on the ablation surface and the effect of cross-linking in the stromal layers adjacent to the ablation zone. Shielding of induced secondary radiation by riboflavin and the formation of a Bowman-like membrane structure made it possible to avoid the development of an irreversible form of fibroplasia and a decrease in visual acuity. The formed membrane structure with cross-linking in the underlying stromal layers was a barrier between pro-inflammatory epithelial and stromal cytokines, which predetermine the development of fibroplasia during photokeratoablation. Conclusion. Photokeratoablation with riboflavin prevents the development of an irreversible form of fibroplasia and can be considered as an alternative to the use of Mitomycin-C in photorefractive and phototherapeutic operations on the cornea by radiation from an argon-fluorine excimer laser. Key words: Mitomycin-C, riboflavin, fibroplasia, excimer laser corneal surgery, laser-induced crosslinking." @default.
- W3169395373 created "2021-06-22" @default.
- W3169395373 creator A5060710817 @default.
- W3169395373 date "2021-05-31" @default.
- W3169395373 modified "2023-09-24" @default.
- W3169395373 title "Photoablation with riboflavin as an alternative to the application of Mitomycin-C in excimer laser corneal surgery" @default.
- W3169395373 doi "https://doi.org/10.25276/2410-1257-2021-2-24-27" @default.
- W3169395373 hasPublicationYear "2021" @default.
- W3169395373 type Work @default.
- W3169395373 sameAs 3169395373 @default.
- W3169395373 citedByCount "0" @default.
- W3169395373 crossrefType "journal-article" @default.
- W3169395373 hasAuthorship W3169395373A5060710817 @default.
- W3169395373 hasConcept C118487528 @default.
- W3169395373 hasConcept C120665830 @default.
- W3169395373 hasConcept C121332964 @default.
- W3169395373 hasConcept C126322002 @default.
- W3169395373 hasConcept C141071460 @default.
- W3169395373 hasConcept C142724271 @default.
- W3169395373 hasConcept C16930146 @default.
- W3169395373 hasConcept C185592680 @default.
- W3169395373 hasConcept C192562407 @default.
- W3169395373 hasConcept C204232928 @default.
- W3169395373 hasConcept C2776155809 @default.
- W3169395373 hasConcept C2776621570 @default.
- W3169395373 hasConcept C2776882836 @default.
- W3169395373 hasConcept C2778305132 @default.
- W3169395373 hasConcept C2778902805 @default.
- W3169395373 hasConcept C2779338040 @default.
- W3169395373 hasConcept C2780477314 @default.
- W3169395373 hasConcept C2780603455 @default.
- W3169395373 hasConcept C520434653 @default.
- W3169395373 hasConcept C52124034 @default.
- W3169395373 hasConcept C55493867 @default.
- W3169395373 hasConcept C71924100 @default.
- W3169395373 hasConcept C74561354 @default.
- W3169395373 hasConceptScore W3169395373C118487528 @default.
- W3169395373 hasConceptScore W3169395373C120665830 @default.
- W3169395373 hasConceptScore W3169395373C121332964 @default.
- W3169395373 hasConceptScore W3169395373C126322002 @default.
- W3169395373 hasConceptScore W3169395373C141071460 @default.
- W3169395373 hasConceptScore W3169395373C142724271 @default.
- W3169395373 hasConceptScore W3169395373C16930146 @default.
- W3169395373 hasConceptScore W3169395373C185592680 @default.
- W3169395373 hasConceptScore W3169395373C192562407 @default.
- W3169395373 hasConceptScore W3169395373C204232928 @default.
- W3169395373 hasConceptScore W3169395373C2776155809 @default.
- W3169395373 hasConceptScore W3169395373C2776621570 @default.
- W3169395373 hasConceptScore W3169395373C2776882836 @default.
- W3169395373 hasConceptScore W3169395373C2778305132 @default.
- W3169395373 hasConceptScore W3169395373C2778902805 @default.
- W3169395373 hasConceptScore W3169395373C2779338040 @default.
- W3169395373 hasConceptScore W3169395373C2780477314 @default.
- W3169395373 hasConceptScore W3169395373C2780603455 @default.
- W3169395373 hasConceptScore W3169395373C520434653 @default.
- W3169395373 hasConceptScore W3169395373C52124034 @default.
- W3169395373 hasConceptScore W3169395373C55493867 @default.
- W3169395373 hasConceptScore W3169395373C71924100 @default.
- W3169395373 hasConceptScore W3169395373C74561354 @default.
- W3169395373 hasIssue "2" @default.
- W3169395373 hasLocation W31693953731 @default.
- W3169395373 hasOpenAccess W3169395373 @default.
- W3169395373 hasPrimaryLocation W31693953731 @default.
- W3169395373 hasRelatedWork W10598231 @default.
- W3169395373 hasRelatedWork W11543293 @default.
- W3169395373 hasRelatedWork W14897231 @default.
- W3169395373 hasRelatedWork W18524927 @default.
- W3169395373 hasRelatedWork W3769782 @default.
- W3169395373 hasRelatedWork W5565348 @default.
- W3169395373 hasRelatedWork W6443549 @default.
- W3169395373 hasRelatedWork W7126827 @default.
- W3169395373 hasRelatedWork W8461334 @default.
- W3169395373 hasRelatedWork W12700947 @default.
- W3169395373 isParatext "false" @default.
- W3169395373 isRetracted "false" @default.
- W3169395373 magId "3169395373" @default.
- W3169395373 workType "article" @default.